Nearly one-third of premature babies suffer from a severe shortage of platelets. A platelet transfusion can be life-saving, but it can also have adverse effects. Researchers at LUMC have developed a decision model that predicts, for each baby, whether a transfusion is beneficial. The study is important for neonatal care, but also demonstrates how medical data and smart research methods can help improve healthcare in general and make it more personalized.
Read more&width=710&height=710)
A driving force
LUMC strongly underpins the idea that ‘Science is the driving force behind innovative healthcare’. Outcomes of top level fundamental, translational and clinical research by LUMC researchers form a strong basis for innovative and qualitative healthcare on a national, European and international level.
A real game changer was the development of the Dutch national research agenda (NWA) in 2015. The agenda reveals the complexity of the issues challenging Dutch society today. These issues are clustered in so called routes. LUMC is involved in many of these routes and contributes this way to solving important societal challenges.